Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Asymmetric Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel chiral phosphonous bis-amino-oxazoline copper complex enables 98% yield in Henry reactions, offering reliable pharmaceutical intermediate supply.
Advanced asymmetric hydrogenation technology for optically active aldehydes and ketones. Reliable fragrance intermediate supplier offering cost-effective, scalable manufacturing solutions.
Patent CN102728407B details a waste-utilizing synthesis for chiral salen catalysts, offering cost reduction in pharmaceutical intermediate manufacturing via single-solvent processes.
Patent CN107417726B reveals PC-Phos ligand enabling high-yield asymmetric cyclization. Delivers supply chain stability and cost efficiency for pharmaceutical intermediates manufacturing.
Patent CN108623564B reveals a high-yield vanadium-catalyzed route for Dextro-Rabeprazole. Discover cost-effective manufacturing and superior enantioselectivity for your supply chain.
Patent CN1439643A details a stable spirocyclic bisphosphine ligand offering 99.5% ee and high turnover numbers for efficient pharmaceutical intermediate manufacturing.
Patent CN103255183B details enzymatic asymmetric reduction for high-purity intermediates. Offers significant cost reduction and supply chain reliability for statin synthesis.
Patent CN102351777A details a novel organocatalytic route for chiral oxindoles. This report analyzes the cost-effective, metal-free synthesis for pharmaceutical intermediates.
Patent CN105315167A reveals a one-step chiral synthesis. This method offers high selectivity and cost reduction for pharmaceutical intermediate manufacturing supply chains.
Patent CN108659046B reveals a robust route for tetramethyl spiroindane ligands. Discover cost-effective synthesis and high-purity supply for asymmetric catalysis.
Patent CN101709023A details a novel synthesis for 2,2',6,6'-tetrahydroxy biphenyl ligands, offering high yields and simplified chiral catalyst production for pharmaceutical applications.
Patent CN102127003B details a novel organocatalytic route for Tamiflu intermediates, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN102924489A details a novel one-step synthesis of tri[(S)-leucinol]zinc bichloride. This report analyzes cost reduction and supply chain reliability for chiral catalyst manufacturing.
Patent CN102850383A details a novel chiral zinc-nitrogen complex enabling efficient asymmetric catalysis for fine chemical manufacturing and supply chain optimization.
Patent CN112010910B details a novel iridium-catalyzed synthesis of chiral ferrocene homoallylamines, offering high yields and enantioselectivity for cost-effective pharmaceutical intermediate manufacturing.
Patent CN1257468A reveals novel Cp*-metal catalysts for efficient asymmetric transfer hydrogenation, offering significant cost reduction in pharmaceutical manufacturing and safer processing.
Patent CN119661593B reveals novel planar chiral ligands enabling high enantioselectivity. Discover supply chain advantages and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN102059145A details a novel copper-catalyzed asymmetric Henry reaction for producing high-purity (S)-octopamine and anticancer intermediates with improved cost efficiency.
Patent CN102351769A details a novel asymmetric synthesis of chiral 2,5-dihydropyrroles with high ee values, offering cost-effective routes for reliable pharmaceutical intermediate suppliers.
Patent CN117946130A reveals a novel cinchona-catalyzed route for chiral spiro indolinone derivatives, offering significant cost reduction and supply chain reliability for anti-tumor drug manufacturing.